Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Regulus Therapeutics Inc (NASDAQ:RGLS)

1.28
Delayed Data
As of 12:36pm ET
 +0.03 / +2.40%
Today’s Change
0.79
Today|||52-Week Range
3.38
-43.11%
Year-to-Date
No recent news for Regulus Therapeutics Inc.

Today’s Trading

Previous close1.25
Today’s open1.23
Day’s range1.16 - 1.28
Volume356,453
Average volume (3 months)826,826
Market cap$129.7M
Dividend yield--
Data as of 12:36pm ET, 10/20/2017

Growth & Valuation

Earnings growth (last year)-43.52%
Earnings growth (this year)+40.00%
Earnings growth (next 5 years)--
Revenue growth (last year)-94.25%
P/E ratioNM
Price/Sales99.52
Price/Book1.18

Competitors

 Today’s
change
Today’s
% change
GLMDGalmed Pharmaceutica...+0.11+1.46%
GTXIGTX Inc+0.14+1.79%
ZFGNZafgen Inc-0.06-1.62%
MEIPMEI Pharma Inc+0.05+1.91%
Data as of 12:36pm ET, 10/20/2017

Financials

Next reporting dateNovember 9, 2017
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$1.2M
Annual profit (last year)-$81.8M
Net profit margin-6,853.94%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, COO &
Director
Joseph P. Hagan
Chief Financial &
Accounting Officer
Daniel R. Chevallard
Corporate headquarters
San Diego, California

Forecasts